Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Large-scale testing (Phase 3)Ended earlyNCT00658593What this trial is testingGemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer NCIC Clinical Trials Group 19
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Early research (Phase 1)Study completedNCT00003427What this trial is testingOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+7 more Memorial Sloan Kettering Cancer Center 36
Not applicableUnknownNCT01438385What this trial is testingInterventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersWho this might be right forAmpullary CancerDuodenal CancerBile Duct Cancer+20 more Weill Medical College of Cornell University 12,000
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Testing effectiveness (Phase 2)Study completedNCT00003557What this trial is testingDolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer University of Chicago 16
Testing effectiveness (Phase 2)Ended earlyNCT00023946What this trial is testingBMS-247550 in Treating Patients With Liver or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT00005938What this trial is testingDX-8951f in Treating Patients With Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00009893What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Alliance for Clinical Trials in Oncology 42
Large-scale testing (Phase 3)Study completedNCT00262769What this trial is testingGemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract TumorsWho this might be right forExtrahepatic Bile Duct CancerGallbladder Cancer University College, London 324
Large-scale testing (Phase 3)Study completedNCT00016380What this trial is testingOndansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenWho this might be right forCancer NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Study completedNCT01766219What this trial is testingCPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By SurgeryWho this might be right forAdult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more Wake Forest University Health Sciences 17
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT01093222What this trial is testingSorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaWho this might be right forExtrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00033462What this trial is testingErlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+8 more National Cancer Institute (NCI) 78
Not applicableEnrolling By InvitationNCT06997913What this trial is testingAdjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）Who this might be right forLymph Node MetastasisNeurovascular InvasionPathology Showed R1 Resection Hengchao Yu 10